MEI Pharma, Inc.
At Close: 4:00 PM
After Market: 8:20 PM
MEIP Stock Price Graph
MEIP Stock Price Today
MEI Pharma, Inc. (MEIP) stock declined over -0.04% intraday to trade at $0.25 a share on NASDAQ. The stock opened with a loss of 0.00% at $0.25 and touched an intraday high of $0.255, falling -0.04% against the last close of $0.25. The MEI Pharma, Inc. in stock market went to a low of $0.239 during the session.
MEIP Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
11455 El Camino Real
San Diego, CA 92130
Contact #:858 369 7100
Sales or Revenue$62.57 Million
5Y Sales Change11.80%
Fiscal Year EndsJun. 2022
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymphoma, as well as in Phase Ib multi-arm trial to treat B-cell malignancies; and Voruciclib, an oral cyclin-dependent kinase 9 inhibitor, which is in Phase Ib clinical trial for acute myeloid leukemia and B-cell malignancies. It also develops ME-344, a mitochondrial inhibitor targeting the oxidative phosphorylation complex that is in Phase I clinical trial for the treatment of human epidermal growth factor receptor 2 negative breast cancer; and Pracinostat, an oral available histone deacetylase inhibitor, which is in Phase II clinical trial to treat patients with myelodysplastic syndrome. MEI Pharma, Inc. has a license, development, and commercialization agreement with Kyowa Kirin Company; a clinical collaboration with BeiGene, Ltd.; a license, development, manufacturing, and commercialization agreement with Helsinn Healthcare SA; and a license agreement with Presage Biosciences, Inc. The company was formerly known as Marshall Edwards, Inc. and changed its name to MEI Pharma, Inc. in July 2012. MEI Pharma, Inc. was incorporated in 2000 and is headquartered in San Diego, California.
Frequently Asked Questions
What is the current MEI Pharma, Inc. (MEIP) stock price?
MEI Pharma, Inc. (NASDAQ: MEIP) stock price is $0.25 in the last trading session. During the trading session, MEIP stock reached the peak price of $0.255 while $0.239 was the lowest point it dropped to. The percentage change in MEIP stock occurred in the recent session was -0.04% while the dollar amount for the price change in MEIP stock was $-0.00.
MEIP's industry and sector of operation?
The NASDAQ listed MEIP is part of Biotechnology industry that operates in the broader Health Care sector. MEI Pharma, Inc. , a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer.
Who are the executives of MEIP?
Mr. David M. Urso B.A., Esq., J.D.
Chief Operating Officer & Gen. Counsel
Mr. Brian G. Drazba B.A., CPA, CPA
Chief Financial Officer & Sec.
Dr. Daniel P. Gold
Pres, Chief Executive Officer & Director
Mr. Eugene Park
Vice President of Marketing
How MEIP did perform over past 52-week?
MEIP's closing price is 0.25% higher than its 52-week low of $0.2 where as its distance from 52-week high of $1.84 is -0.86%.
How many employees does MEIP have?
Number of MEIP employees currently stands at 102. MEIP operates from 11455 El Camino Real, San Diego, CA 92130, United States.
Link for MEIP official website?
Official Website of MEIP is: https://www.meipharma.com
How do I contact MEIP?
MEIP could be contacted at phone #858 369 7100 and can also be accessed through its website. MEIP operates from 11455 El Camino Real, San Diego, CA 92130, United States.
How many shares of MEIP are traded daily?
MEIP stock volume for the day was 2,209,324 shares. The average number of MEIP shares traded daily for last 3 months was 1.1 Million.
What is the market cap of MEIP currently?
The market value of MEIP currently stands at $35.52 Million with its latest stock price at $0.25 and 133.26 Million of its shares outstanding.